William R. Bishai
Affiliations: | 2004 | Infectious Diseases | Johns Hopkins University, Baltimore, MD |
Area:
molecular pathogenesis of tuberculosisWebsite:
http://www.hopkinsmedicine.org/DOM/TB_Lab/faculty/bishai.htmlGoogle:
"William Ramses Bishai"Bio:
https://www.hhmi.org/scientists/william-r-bishai
http://www.experts.scival.com/jhu/expert.asp?n=William+Ramses+Bishai&u_id=4152
Cross-listing: Chemistry Tree
Parents
Sign in to add mentor| John R. Murphy | grad student | 1989 | Harvard Medical School | |
| (Genetic construction, expression, and characterization of targeted diphtheria toxin fragments) | ||||
| Hamilton O. Smith | post-doc | 1991 | Johns Hopkins Medical School (Chemistry Tree) | |
Children
Sign in to add trainee| James E. Gomez | grad student | 2000 | Johns Hopkins (Microtree) |
| Bahrie Bellete | grad student | 2001 | Johns Hopkins |
| Gyanu Lamichhane | grad student | 2004 | Johns Hopkins (Chemistry Tree) |
| Nicholas Anh Be | grad student | 2011 | Johns Hopkins |
| Pankaj Kumar | post-doc | 2017- | Johns Hopkins Medical School (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Auld SC, Barczak AK, Bishai W, et al. (2024) Pathogenesis of Post-Tuberculosis Lung Disease: Defining Knowledge Gaps and Research Priorities at the 2 International Post-Tuberculosis Symposium. American Journal of Respiratory and Critical Care Medicine |
| Shaku MT, Um PK, Ocius KL, et al. (2024) A modified BCG with depletion of enzymes associated with peptidoglycan amidation induces enhanced protection against tuberculosis in mice. Elife. 13 |
| Yabaji SM, Zhernovkov V, Araveti PB, et al. (2024) Myc Dysregulation in Activated Macrophages Initiates Iron-Mediated Lipid Peroxidation that Fuels Type I Interferon and Compromises TB Resistance. Biorxiv : the Preprint Server For Biology |
| Krug S, Gupta M, Kumar P, et al. (2023) Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide. Nature Communications. 14: 8161 |
| Parveen S, Shen J, Lun S, et al. (2023) Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis. Nature Communications. 14: 7427 |
| Koleske BN, Jacobs WR, Bishai WR. (2023) The Mycobacterium tuberculosis genome at 25 years: lessons and lingering questions. The Journal of Clinical Investigation. 133 |
| Bullen CK, Singh AK, Krug S, et al. (2023) MDA5 RNA sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival. Jci Insight |
| Dabitao D, Bishai WR. (2023) Sex and Gender Differences in Tuberculosis Pathogenesis and Treatment Outcomes. Current Topics in Microbiology and Immunology. 441: 139-183 |
| Baya B, Sanogo I, Kone M, et al. (2023) Relationship between patient sex and anatomical sites of extrapulmonary tuberculosis in Mali. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 33: 100389 |
| Shaku MT, Um P, Ocius KL, et al. (2023) A modified BCG with depletion of enzymes associated with peptidoglycan amidation induces enhanced protection against tuberculosis in mice. Biorxiv : the Preprint Server For Biology |